We utilized the K14-Cre Brca1<sup>f/f</sup>Tp53<sup>f/f</sup> mouse model to investigate whether a pulse of PARP inhibitor (PARPi) ± an AKT inhibitor (AKTi) can prevent Brca1-related breast cancer. This evidence concerns the gene TP53 and breast carcinoma.